Integrating Behavioral Health and Primary Care (IBH-PC) to improve patient-centered outcomes in adults with multiple chronic medical and behavioral health conditions: study protocol for a pragmatic cluster-randomized control trial.


Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
10 Mar 2021
Historique:
received: 23 09 2020
accepted: 15 02 2021
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 22 6 2021
Statut: epublish

Résumé

Chronic diseases that drive morbidity, mortality, and health care costs are largely influenced by human behavior. Behavioral health conditions such as anxiety, depression, and substance use disorders can often be effectively managed. The majority of patients in need of behavioral health care are seen in primary care, which often has difficulty responding. Some primary care practices are providing integrated behavioral health care (IBH), where primary care and behavioral health providers work together, in one location, using a team-based approach. Research suggests there may be an association between IBH and improved patient outcomes. However, it is often difficult for practices to achieve high levels of integration. The Integrating Behavioral Health and Primary Care study responds to this need by testing the effectiveness of a comprehensive practice-level intervention designed to improve outcomes in patients with multiple chronic medical and behavioral health conditions by increasing the practice's degree of behavioral health integration. Forty-five primary care practices, with existing onsite behavioral health care, will be recruited for this study. Forty-three practices will be randomized to the intervention or usual care arm, while 2 practices will be considered "Vanguard" (pilot) practices for developing the intervention. The intervention is a 24-month supported practice change process including an online curriculum, a practice redesign and implementation workbook, remote quality improvement coaching services, and an online learning community. Each practice's degree of behavioral health integration will be measured using the Practice Integration Profile. Approximately 75 patients with both chronic medical and behavioral health conditions from each practice will be asked to complete a series of surveys to measure patient-centered outcomes. Change in practice degree of behavioral health integration and patient-centered outcomes will be compared between the two groups. Practice-level case studies will be conducted to better understand the contextual factors influencing integration. As primary care practices are encouraged to provide IBH services, evidence-based interventions to increase practice integration will be needed. This study will demonstrate the effectiveness of one such intervention in a pragmatic, real-world setting. ClinicalTrials.gov NCT02868983 . Registered on August 16, 2016.

Sections du résumé

BACKGROUND BACKGROUND
Chronic diseases that drive morbidity, mortality, and health care costs are largely influenced by human behavior. Behavioral health conditions such as anxiety, depression, and substance use disorders can often be effectively managed. The majority of patients in need of behavioral health care are seen in primary care, which often has difficulty responding. Some primary care practices are providing integrated behavioral health care (IBH), where primary care and behavioral health providers work together, in one location, using a team-based approach. Research suggests there may be an association between IBH and improved patient outcomes. However, it is often difficult for practices to achieve high levels of integration. The Integrating Behavioral Health and Primary Care study responds to this need by testing the effectiveness of a comprehensive practice-level intervention designed to improve outcomes in patients with multiple chronic medical and behavioral health conditions by increasing the practice's degree of behavioral health integration.
METHODS METHODS
Forty-five primary care practices, with existing onsite behavioral health care, will be recruited for this study. Forty-three practices will be randomized to the intervention or usual care arm, while 2 practices will be considered "Vanguard" (pilot) practices for developing the intervention. The intervention is a 24-month supported practice change process including an online curriculum, a practice redesign and implementation workbook, remote quality improvement coaching services, and an online learning community. Each practice's degree of behavioral health integration will be measured using the Practice Integration Profile. Approximately 75 patients with both chronic medical and behavioral health conditions from each practice will be asked to complete a series of surveys to measure patient-centered outcomes. Change in practice degree of behavioral health integration and patient-centered outcomes will be compared between the two groups. Practice-level case studies will be conducted to better understand the contextual factors influencing integration.
DISCUSSION CONCLUSIONS
As primary care practices are encouraged to provide IBH services, evidence-based interventions to increase practice integration will be needed. This study will demonstrate the effectiveness of one such intervention in a pragmatic, real-world setting.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT02868983 . Registered on August 16, 2016.

Identifiants

pubmed: 33691772
doi: 10.1186/s13063-021-05133-8
pii: 10.1186/s13063-021-05133-8
pmc: PMC7945346
doi:

Banques de données

ClinicalTrials.gov
['NCT02868983']

Types de publication

Clinical Trial Protocol Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

200

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK111022
Pays : United States
Organisme : NCIPC CDC HHS
ID : R01 CE003008
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA047982
Pays : United States
Organisme : Patient-Centered Outcomes Research Institute
ID : PCS-1409-24372
Pays : United States

Références

Transl Behav Med. 2012 Sep;2(3):337-44
pubmed: 24073133
Heart Lung. 2018 Sep - Oct;47(5):465-470
pubmed: 30087002
Drug Alcohol Depend. 2017 Aug 1;177:104-111
pubmed: 28582698
Drug Alcohol Depend. 2018 May 01;186:207-214
pubmed: 29609132
Fam Syst Health. 2016 Dec;34(4):342-356
pubmed: 27736110
N Engl J Med. 2005 Jun 16;352(24):2515-23
pubmed: 15958807
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
J Am Board Fam Med. 2012 Mar-Apr;25(2):255-9
pubmed: 22403211
Ann Fam Med. 2014 Mar-Apr;12(2):183-5
pubmed: 24615323
J Allergy Clin Immunol. 2012 Nov;130(5):1078-84
pubmed: 23026499
Ann Rheum Dis. 2015 Jan;74(1):104-7
pubmed: 24095937
Vital Health Stat 10. 1999 Oct;(200):1-203
pubmed: 15782448
Fam Syst Health. 2016 Dec;34(4):334-341
pubmed: 27736111
J Clin Psychol Med Settings. 2008 Mar;15(1):65-72
pubmed: 19104956
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Fam Pract. 2015 Feb;32(1):3-15
pubmed: 25248976
BMC Med. 2010 Jun 25;8:38
pubmed: 20579335
Prim Care. 2019 Dec;46(4):515-527
pubmed: 31655748
CMAJ. 2001 Nov 13;165(10):1339-41
pubmed: 11760981
JAMA. 1999 Nov 10;282(18):1737-44
pubmed: 10568646
Am J Cardiol. 1989 Sep 15;64(10):651-4
pubmed: 2782256
J Am Board Fam Med. 2017 Mar-Apr;30(2):130-139
pubmed: 28379819
Ann Fam Med. 2014 Mar-Apr;12(2):172-5
pubmed: 24615314
Ment Health Fam Med. 2013 Dec;10(4):191-202
pubmed: 25632302
Ann Pharmacother. 1999 Mar;33(3):281-8
pubmed: 10200850
J Am Board Fam Med. 2015 Sep-Oct;28 Suppl 1:S21-31
pubmed: 26359469
Chest. 1998 Oct;114(4):998-1007
pubmed: 9792568
J Clin Epidemiol. 2010 Nov;63(11):1179-94
pubmed: 20685078
Health Aff (Millwood). 2009 May-Jun;28(3):w490-501
pubmed: 19366722
Cogn Behav Ther. 2011;40(3):216-27
pubmed: 21770844
J Clin Epidemiol. 2011 May;64(5):507-16
pubmed: 21447427
Am J Addict. 2006;15 Suppl 1:80-91
pubmed: 17182423
Jt Comm J Qual Patient Saf. 2005 May;31(5):249-57
pubmed: 15960015
Ann Fam Med. 2013 May-Jun;11 Suppl 1:S115-23
pubmed: 23690380
J Am Board Fam Med. 2015 Sep-Oct;28 Suppl 1:S7-20
pubmed: 26359474
N Engl J Med. 2010 Dec 30;363(27):2611-20
pubmed: 21190455
JAMA. 2004 Mar 10;291(10):1238-45
pubmed: 15010446
Synth Proj Res Synth Rep. 2011 Feb;(21):1-26
pubmed: 21675009
Fam Pract. 2004 Dec;21(6):699-705
pubmed: 15528286
Adm Policy Ment Health. 2013 Sep;40(5):384-99
pubmed: 22833051
BMC Med Res Methodol. 2006 May 03;6:20
pubmed: 16672056
Clin Trials. 2004;1(6):532-44
pubmed: 16279294
Ann Fam Med. 2015 Jan-Feb;13(1):56-68
pubmed: 25583894
Med Care. 1986 Jan;24(1):67-74
pubmed: 3945130
J Fam Pract. 2001 Oct;50(10):864-70
pubmed: 11674889
J Am Board Fam Med. 2014 Sep-Oct;27(5):637-44
pubmed: 25201933
Ann Fam Med. 2005 May-Jun;3 Suppl 1:S38-45
pubmed: 15928217

Auteurs

Abigail M Crocker (AM)

University of Vermont, Burlington, VT, USA. abigail.crocker@uvm.edu.

Rodger Kessler (R)

Arizona State University, Tempe, AZ, USA.
School of Medicine, University of Colorado, Aurora, CO, USA.

Constance van Eeghen (C)

University of Vermont, Burlington, VT, USA.

Levi N Bonnell (LN)

University of Vermont, Burlington, VT, USA.

Ryan E Breshears (RE)

Wellstar Health System, Marietta, GA, USA.

Peter Callas (P)

University of Vermont, Burlington, VT, USA.

Jessica Clifton (J)

University of Vermont, Burlington, VT, USA.

William Elder (W)

University of Houston College of Medicine, Houston, TX, USA.

Chet Fox (C)

University at Buffalo, Buffalo, NY, USA.

Sylvie Frisbie (S)

University of Vermont, Burlington, VT, USA.

Juvena Hitt (J)

University of Vermont, Burlington, VT, USA.

Jennifer Jewiss (J)

University of Vermont, Burlington, VT, USA.

Roger Kathol (R)

University of Minnesota, Minneapolis, MN, USA.

Kelly Clark/Keefe (K)

University of Vermont, Burlington, VT, USA.

Jennifer O'Rourke-Lavoie (J)

University of Vermont, Burlington, VT, USA.

George S Leibowitz (GS)

Stony Brook University, Stony Brook, NY, USA.

C R Macchi (CR)

Arizona State University, Tempe, AZ, USA.

Mark McGovern (M)

School of Medicine, Stanford University, Palo Alto, CA, USA.

Brenda Mollis (B)

University of Washington, Seattle, WA, USA.

Daniel J Mullin (DJ)

School of Medicine, University of Massachusetts, Worcester, MA, USA.

Zsolt Nagykaldi (Z)

Health Sciences Center, University of Oklahoma, Oklahoma City, OK, USA.

Lisa Watts Natkin (LW)

University of Vermont, Burlington, VT, USA.

Wilson Pace (W)

DARTNet Institute, Aurora, CO, USA.

Richard G Pinckney (RG)

University of Vermont, Burlington, VT, USA.

Douglas Pomeroy (D)

University of Vermont, Burlington, VT, USA.

Alexander Pond (A)

University of Vermont, Burlington, VT, USA.

Rachel Postupack (R)

CHE Behavioral Health Services, New York City, NY, USA.

Paula Reynolds (P)

University of Vermont, Burlington, VT, USA.

Gail L Rose (GL)

University of Vermont, Burlington, VT, USA.

Sarah Hudson Scholle (SH)

National Committee for Quality Assurance, Washington, DC, USA.

William J Sieber (WJ)

University of California San Diego, San Diego, CA, USA.

Terry Stancin (T)

MetroHealth System, Cleveland, OH, USA.

Kurt C Stange (KC)

Case Western Reserve University, Cleveland, OH, USA.

Kari A Stephens (KA)

University of Washington, Seattle, WA, USA.

Kathryn Teng (K)

MetroHealth System, Cleveland, OH, USA.

Elizabeth Needham Waddell (EN)

Oregon Health & Science University, Portland, OR, USA.

Benjamin Littenberg (B)

University of Vermont, Burlington, VT, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH